{
    "clinical_study": {
        "@rank": "137876", 
        "arm_group": {
            "arm_group_label": "Personal Heart Rhythm Monitor", 
            "arm_group_type": "Experimental", 
            "description": "Intermittent cardiac monitoring with a Personal Heart Rhythm Monitor for three months."
        }, 
        "brief_summary": {
            "textblock": "This study aims to determine the sensitivity and specificity of a Personal Heart Rhythm\n      Monitor in the detection of prolonged paroxysmal atrial fibrillation (defined as lasting\n      more than 12 hours) against pre-existing implantable devices, seen to be the 'gold-standard'\n      for arrhythmia detection."
        }, 
        "brief_title": "Testing the Accuracy of a Personal Heart Rhythm Monitor to Detect Prolonged Paroxysmal Atrial Fibrillation", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Paroxysmal Atrial Fibrillation", 
            "Stroke"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atrial Fibrillation", 
                "Stroke"
            ]
        }, 
        "detailed_description": {
            "textblock": "The Investigators aim to recruit 30 volunteers with implantable devices (either conventional\n      pacemakers, with an atrial lead or implantable loop recorders, devices inserted under the\n      skin to monitor the heart rhythm). They will be attending for their routine pacemaker checks\n      in a number of clinics in Surrey.\n\n      Potential participants will have documented prolonged paroxysmal atrial fibrillation (PAF,\n      an intermittent irregular heart rhythm which is known to predispose to stroke),  lasting at\n      least 12 hours, identified in the last month prior to the pacemaker check.\n\n      Willing patients will then be issued with a PHRM (Personal Heart Rhythm Monitor) device to\n      make heart rhythm recordings for 3 months.  They will do this twice-daily for 30 seconds for\n      this period.  At the end of the 3 month period patients will undergo a final pacing device\n      check.  Identification of prolonged PAF using the PHRM device will be compared to the\n      implantable device."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Prolonged AF (defined as an episode at least 12 hours duration) in the last month\n             whilst attending routine pacemaker check\n\n          -  Pacing requirement < 25% during the last month\n\n        Exclusion Criteria:\n\n          -  Lack of capacity\n\n          -  Inability to use the Personal Heart Rhythm Monitor due to cognitive or physical\n             impairment\n\n          -  Commencement of new anti-arrhythmic drug since last pacemaker check"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01917981", 
            "org_study_id": "HASTE-1"
        }, 
        "intervention": {
            "arm_group_label": "Personal Heart Rhythm Monitor", 
            "intervention_name": "Personal Heart Rhythm Monitor", 
            "intervention_type": "Device", 
            "other_name": "Portable ECG monitor HCG-801 - OMRON Healthcare"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Intermittent cardiac monitoring", 
            "Implantable device"
        ], 
        "lastchanged_date": "May 20, 2014", 
        "link": [
            {
                "description": "HASTE charity website", 
                "url": "http://www.haste.uk.com/"
            }, 
            {
                "description": "HASTE Academy website", 
                "url": "http://www.hasteacademy.org/"
            }
        ], 
        "location": [
            {
                "contact": {
                    "last_name": "Riyaz Kaba, MBChB MRCP"
                }, 
                "facility": {
                    "address": {
                        "city": "Chertsey", 
                        "country": "United Kingdom", 
                        "state": "Surrey", 
                        "zip": "KT16 0PJ"
                    }, 
                    "name": "St Peter's Hospital"
                }, 
                "investigator": {
                    "last_name": "Riyaz Kaba, MRCP", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "philippah@doctors.org.uk", 
                    "last_name": "Philippa J Howlett, MBChB BSc MRCP"
                }, 
                "facility": {
                    "address": {
                        "city": "Guildford", 
                        "country": "United Kingdom", 
                        "state": "Surrey", 
                        "zip": "GU2 7XX"
                    }, 
                    "name": "Royal Surrey County Hospital NHS Foundation Trust"
                }, 
                "investigator": [
                    {
                        "last_name": "Edward W Leatham, MBChB MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Philippa J Howlett, MBChB", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "1", 
        "official_title": "Testing the Accuracy of an Intermittent Personal Heart Rhythm Monitor (PHRM) to Detect Prolonged Paroxysmal Atrial Fibrillation (PAF) Against Implantable Devices.", 
        "overall_contact": {
            "email": "philippah@doctors.org.uk", 
            "last_name": "Philippa J Howlett, MBChB BSc"
        }, 
        "overall_contact_backup": {
            "email": "eleatham@mail.scvc.co.uk", 
            "last_name": "Edward W Leatham, MBChB MD"
        }, 
        "overall_official": {
            "affiliation": "The University of Surrey and The Royal Surrey County Hospital", 
            "last_name": "Philippa J Howlett, MBChB MRCP", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: National Health Service", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measured (%) as the number of identified episodes of prolonged PAF using the PHRM compared to the gold standard implantable device in all patients over the 3 month period.", 
            "measure": "The sensitivity and specificity of detection of prolonged paroxysmal atrial fibrillation (PAF) using a Personal Heart Rhythm Monitor (PHRM), compared to an implantable device.", 
            "safety_issue": "No", 
            "time_frame": "18 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01917981"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measured (%) as the number of identified episodes of all episodes of PAF (lasting at least 30 seconds) using the PHRM compared to the gold standard implantable device in all patients over the 3 month period.", 
                "measure": "The sensitivity and specificity of detection of all episodes of PAF using a PHRM, compared to an implantable device.", 
                "safety_issue": "No", 
                "time_frame": "18 months"
            }, 
            {
                "description": "Measured as actual number of recordings made out of 180 requested recordings and expressed as a percentage.", 
                "measure": "Participant compliance with twice-daily recordings with the PHRM for a three month period.", 
                "safety_issue": "No", 
                "time_frame": "18 months"
            }, 
            {
                "description": "The agreement in the diagnosis of normal sinus rhythm and PAF using PHRM recordings between a Research Nurse and Cardiologist expressed as a percentage.", 
                "measure": "The concordance of the interpretation of PHRM recordings by a Research Nurse and blinded Cardiologist.", 
                "safety_issue": "No", 
                "time_frame": "18 months"
            }
        ], 
        "source": "University of Surrey", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Royal Surrey County Hospital NHS Foundation Trust", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Ashford and St. Peter's Hospitals NHS Trust", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Surrey", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}